Abstract 6549: Integrating functional biosignatures and same-cell spatial multiomics to predict synergistic benefit of combination checkpoint therapy in head and neck cancer
Yi Cui(Kunming University of Science and Technology), Satish Sankaran(Anthem Biosciences (India)), Shanshan He(Nanostring Technologies (United States)), Joseph Beechem(Bruker (Switzerland)), Daniel McGuire(Bruker (United States)), Biswajit Das(Anthem Biosciences (India)), Claire Williams(Bruker (United States)), Michael Emilio Patrick(Bruker (United States)), Mohit Malhotra(Anthem Biosciences (India)), Moumita Nath(Anthem Biosciences (India)), Jobin K. Paul(Anthem Biosciences (India)), Kowshik Jaganathan(Anthem Biosciences (India))
Cited by 0
Related Papers
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non–Small Cell Lung Cancer
|JAMA Oncology|2017|603
Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment
|Nature Genetics|2022|415